NL-OMON45898招募中不适用
A phase I/II Study to Evaluate the Safety and Feasibility of Dual-modality imaging using Indium-111-DOTA-labetuzumab-IRDye800CW in patients with Peritoneal Carcinomatosis of Colorectal Origin - The DuMoPEC study
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 29
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational invasive
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Clinical diagnosis of peritoneal carcinomatosis of colorectal origin.
- •Scheduled for cytoreductive surgery and HIPEC.
- •Age over 18 years
- •Signed informed consent
排除标准
- •Any medical condition present that in the opinion of the investigator will affect patients* clinical status.
- •Administration of a radionuclide within 10 physical half- lives prior to study enrollment
- •Pregnancy or lactation
- •Very high (>500 ng/ml) serum CEA levels
- •Immunohistochemically proven non-CEA expressing primary tumor (if analyzed in primary tumor resection specimen)
研究者
相似试验
进行中（未招募）
1 期
Safety and Efficacy of AMG 592 in Subjects with Active Rheumatoid ArthritisMedDRA version: 20.0Level: HLTClassification code 10039075Term: Rheumatoid arthritis and associated conditionsSystem Organ Class: 100000004870Rheumatoid ArthritisEUCTR2017-001944-36-BGAmgen Inc153
进行中（未招募）
1 期
Safety and Efficacy of AMG 592 in Subjects with Active Rheumatoid ArthritisMedDRA version: 20.0Level: HLTClassification code 10039075Term: Rheumatoid arthritis and associated conditionsSystem Organ Class: 100000004870Rheumatoid ArthritisEUCTR2017-001944-36-PLAmgen Inc153
进行中（未招募）
1 期
Safety and Efficacy of AMG 592 in Subjects With Active Systemic Lupus ErythematosusMedDRA version: 21.1Level: LLTClassification code 10025139Term: Lupus erythematosus systemicSystem Organ Class: 100000004859Systemic Lupus ErythematosusEUCTR2017-002564-40-DEAmgen Inc140
进行中（未招募）
1 期
Safety and Efficacy of AMG 592 in Subjects with Active Rheumatoid ArthritisMedDRA version: 20.0Level: HLTClassification code 10039075Term: Rheumatoid arthritis and associated conditionsSystem Organ Class: 100000004870Rheumatoid ArthritisEUCTR2017-001944-36-ESAmgen Inc36
进行中（未招募）
1 期
aEUCTR2019-004883-23-FRAPHP